Carnegie Investment Counsel’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
AI
PAM
Carnegie Investment Counsel's CME Position: Q2 2026 in Review
Carnegie Investment Counsel reduced its CME Group (CME) stake by 1.7% in Q2 2026, selling an estimated $774K and leaving 159,681 shares worth $33.5M. The position accounts for 0.67% of the portfolio, ranked #40.
Carnegie Investment Counsel first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $45.7M in Q1 2026. 956 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Carnegie Investment Counsel held 159,681 shares of CME Group worth $33.5M as of Q2 2026.
- Carnegie Investment Counsel sold 2,797 CME Group shares in Q2 2026, an estimated $774K.
- CME Group made up 0.67% of Carnegie Investment Counsel's portfolio in Q2 2026, its #40 holding.
- Carnegie Investment Counsel first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
- Carnegie Investment Counsel's CME Group position peaked at $45.7M in Q1 2026.
- 956 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Carnegie Investment Counsel's 13F filing for Q2 2026, filed 30 Jul 2026.